Welcome to the LDN Radio Show brought to you by the LDN Research Trust. I'm your host Linda Elsegood. Today we're joined by Ray Solano from PD Labs. He's also a nutritionist. Could you tell us a bit of background about yourself?

 

Welcome to the LDN Radio Show brought to you by the LDN Research Trust. I'm your host Linda Elsegood. 

Dr Steve Zielinski is here today. Can you tell us who are you? What made you decide you wanted to be a pharmacist? 

The Toronto Functional Medicine Centre IV Lounge Explains How Nutritional Support May Help Manage Fibromyalgia and Chronic Fatigue Syndrome

Will LDN therapy improve the quality of life of patients with fibromyalgia? (in Polish) (News)

05 May 2023
Medexpress.pl
https://www.medexpress.pl/blogosfera/czy-terapia-ldn-poprawi-jakosc-zycia-pacjentow-z-fibromialgia/

Pain associated with fibromyalgia: Benefits from low-dose naltrexone (in Italian)

National Courier
22 May 2023
https://www.corrierenazionale.it/2023/05/22/dolore-associato-alla-fibromialgia-benefici-da-basse-dosi-di-naltrexone/?noamp=mobile

A systematic literature review on the clinical efficacy of low dose naltrexone and its effect on putative pathophysiological mechanisms among patients diagnosed with fibromyalgia

Heliyon
19 April 2023
https://pubmed.ncbi.nlm.nih.gov/37206027/

Low-Dose Naltrexone in Rheumatological Diseases

Mediterr J Rheumatol
31 March 2023
https://pubmed.ncbi.nlm.nih.gov/37223594/

Background: Naltrexone has been approved for alcohol and opioid abuse by the FDA. At low-dose naltrexone (LDN) has been used in several diseases including chronic pain and autoimmune conditions, including rheumatic disorders.

Low-dose naltrexone in the treatment of fibromyalgia: A systematic review and narrative synthesis

Aust J Gen Pract
April 2023
https://www1.racgp.org.au/ajgp/2023/april/low-dose-naltrexone-in-the-treatment-of-fibromyalg

Method: A systematic literature search was conducted using the key words 'naltrexone', 'fibromyalgia', 'fibrositis', 'chronic pain' and 'neurogenic inflammation'.

Face Blindness & Long COVID: Prosopagnosia Is a New Symptom of Long COVID

30seconds.com
10 April 2023
https://30seconds.com/health/tip/57734/Face-Blindness-Long-COVID-Prosopagnosia-Is-a-New-Symptom-of-Long-COVID

Efficacy of Low-Dose Naltrexone and Predictors of Treatment Success or Discontinuation in Fibromyalgia and Other Chronic Pain Conditions: A Fourteen-Year, Enterprise-Wide Retrospective Analysis

Biomedicines
As revised 23 March 2023
https://www.mdpi.com/2227-9059/11/4/1087